Ki-67、TSP-1、VEGF与前列腺癌合并代谢综合症的研究进展

德泉 冉(承德医学院附属医院泌尿外科，中国)
辉 徐(承德医学院附属医院泌尿外科，中国)

摘要

前列腺癌是男性最常见的泌尿生殖系统肿瘤之一，近年其发病率呈逐年升高趋势，在发达国家尤为明显。在中国，随着饮食及生活方式的改变，前列腺癌患者也逐年增多。另外，随着中国老龄化严重，代谢综合征患者也呈增长趋势。多项研究已经证实，代谢综合征为前列腺癌发病的重要危险因素之一，但对其作用机制仍有很大争议。论文旨在通过对Ki-67、TSP-1、VEGF对于前列腺癌伴代谢综合征患者的影响做一综述，为前列腺癌伴代谢综合征患者的临床诊断及预后提供依据。

关键词

前列腺癌；代谢综合征；KI-67；TSP-1；VEGF

参考

Siegel R L, Miller K D, Wagle N S, et al. Cancer statistics, 2023[J]. CA: A Cancer Journal for Clinicians, 2023,73(1):17-48.

王劲松,魏家燕,彭敏.2023年美国癌症统计报告和全球最新癌症统计数据解读及启示[J].实用肿瘤杂志,2023,38(6):523-527.

Jian Gang P, Mo L, Lu Y, et al. Diabetes mellitus and the risk of prostate cancer: an update and cumulative meta-analysis[J]. Endocrine Research, 2015,40(1):54-61.

Liang Z, Xie B, Li J, et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis[J]. Scientific Reports, 2016,6(1):31358.

Andreassen O A, Zuber V, Thompson W K, et al. Shared common variants in prostate cancer and blood lipids[J]. International Journal of Epidemiology, 2014,43(4):1205-1214.

中国2型糖尿病防治指南(2020年版)(下)[J].中国实用内科杂志,2021,41(9):757-784.

Zhang C, Zhang L, Tian Y, et al. Association between metabolic syndrome and early-stage colorectal cancer[J]. BMC Cancer, 2023,23(1):1020.

Blanc-Lapierre A, Spence A, Karakiewicz P I, et al. Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada[J]. BMC Public Health, 2015,15(1):913.

Wilson R L, Taaffe D R, Newton R U, et al. Obesity and prostate cancer: A narrative review[J]. Critical Reviews in Oncology/Hematology, 2022,169:103543.

Pai P Y, Hsieh V C R, Wang C B, et al. Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis[J]. International Journal of Cardiology, 2015,193:1-7.

Sciacca L, Vigneri R, Tumminia A, et al. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients[J]. Nutrition, Metabolism and Cardiovascular Diseases, 2013,23(9):808-815.

Wuermli L, Joerger M, Henz S, et al. Hypertriglyceridemia as a possible risk factor for prostate cancer[J]. Prostate Cancer and Prostatic Diseases, 2005,8(4):316-320.

Fulton R. Getting a Grip on Ki-67[J]. Applied Immunohistochemistry & Molecular Morphology, 2021,29(2):83-85.

吴鹏杰,张伟,刘圣杰,等.P53、Ki-67蛋白在前列腺癌的表达及其临床意义[J].现代泌尿外科杂志,2023,28(5):421-423.

单孝军,刘宝翠,张丽君,等.Her-2、Ki-67在合并2型糖尿病的乳腺癌患者中的表达及意义[J].糖尿病新世界,2019,22(19):23-24.

Sun S, Dong H, Yan T, et al. Role of TSP-1 as prognostic marker in various cancers: a systematic review and meta-analysis[J]. BMC Medical Genetics, 2020,21(1):139.

龙军,陈林,汪松,等.TSP1在泌尿系统中的研究进展[J].中国肿瘤外科杂志,2023,15(6):609-614.

Bastian M, Steiner M, Schuff-Werner P. Expression of thrombospondin-1 in prostate-derived cell lines[J]. International Journal of Molecular Medicine, 2005.

Kerr B A, Harris K S, Shi L, et al. Platelet TSP-1 Controls Prostate Cancer-Induced Osteoclast Differentiation and Bone Marrow-Derived Cell Mobilization through TGFβ-1[M]. (2020-02-12).

Xu L, Zhang Y, Chen J, et al. Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications[J]. Journal of Diabetes Research, 2020,2020:1-14.

Ahmad A, Nawaz M I. Molecular mechanism of VEGF and its role in pathological angiogenesis[J]. Journal of Cellular Biochemistry, 2022, 123(12):1938-1965.

蓝雪灵,黄燕妮,朱敏敏,等.抗VEGF及其受体分子靶向药物治疗肝癌机制的研究进展[J].中国临床药理学与治疗学,2024,29(6):707-714.

Wu H, Ma T, Li D, et al. Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization[J]. Frontiers in Genetics.

孙旭东,乔庆东,王磊,等.血清VEGF、PSA水平与前列腺癌根治术后短期预后的相关性分析[J].医学理论与实践,2022,35(1):118-120.

Wang M, Wisniewski C A, Xiong C, et al. Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer[J]. Science Translational Medicine, 2023,15(694):eade5855.

Yang J, Liu Z. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy[J]. Frontiers in Endocrinology, 2022,13:816400.

DOI: http://dx.doi.org/10.12345/yzlcyxzz.v7i8.20485